BCL3 and plasma cell myeloma: In Multiple Myeloma (MM), but not hepatocellular carcinoma, ChIP and Luciferase gene reporter assays demonstrated IL-6 to regulate BCL3 expression via the binding of STAT3 to the HS4 BCL3 gene enhancer.